Fresenius SE Market Cap 2016-2024 | FSNUY
Fresenius SE market cap history and chart from 2016 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Fresenius SE market cap as of January 10, 2025 is $19.26B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $19.257B | $24.011B |
| Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quest Diagnostics (DGX) | United States | $16.849B | 17.08 |
| DaVita (DVA) | United States | $12.285B | 15.89 |
| Encompass Health (EHC) | United States | $9.254B | 21.82 |
| Chemed (CHE) | United States | $7.946B | 24.42 |
| Elanco Animal Health (ELAN) | United States | $5.957B | 14.18 |
| RadNet (RDNT) | United States | $5.193B | 115.00 |
| Option Care Health (OPCH) | United States | $3.863B | 18.31 |
| Amedisys (AMED) | United States | $2.977B | 21.19 |
| LifeStance Health (LFST) | United States | $2.889B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.253B | 26.44 |
| Astrana Health (ASTH) | United States | $1.811B | 24.77 |
| U.S Physical Therapy (USPH) | United States | $1.327B | 34.87 |
| Pennant (PNTG) | United States | $0.909B | 36.75 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.871B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.268B | 0.00 |
| Bioqual (BIOQ) | United States | $0.058B | 0.00 |
| Daxor (DXR) | United States | $0.037B | 0.00 |
| Ontrak (OTRK) | United States | $0.008B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.005B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.003B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |